Global Lyme Disease Diagnostic Devices Market Intelligence Brief (2026–2036)
Market Overview
The global Lyme disease diagnostic devices market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Lyme disease, caused by Borrelia burgdorferi and transmitted through tick bites, remains one of the most common vector-borne diseases in North America and Europe. Rising incidence rates, growing awareness, and advancements in molecular diagnostics are driving demand for accurate and rapid diagnostic devices.
Impact of COVID-19
COVID-19 disrupted healthcare systems worldwide, initially diverting resources away from Lyme disease diagnostics. However, the pandemic accelerated innovation in molecular testing platforms, which indirectly benefited Lyme disease diagnostics. Increased adoption of point-of-care testing and heightened awareness of infectious diseases have created long-term opportunities for diagnostic device manufacturers.
Market Segmentation
By Type
- Serological Tests (ELISA, Western Blot)
- Lymphocytic Transformation Tests
- PCR Analysis (Polymerase Chain Reaction)
- Immunofluorescence Staining
- Rapid Point-of-Care Tests
- Next-Generation Sequencing (NGS)-based Assays
By Application
- Hospital Laboratories
- Diagnostic Centers
- Research Institutes
- Point-of-Care Testing (POCT)
- Others
Regional Analysis
- North America: Largest market share due to high prevalence of Lyme disease in the U.S. and Canada, strong healthcare infrastructure, and advanced diagnostic technologies.
- Europe: Significant demand in Germany, U.K., and France; Eastern Europe shows rising incidence rates.
- Asia-Pacific: Emerging market with growing awareness; Japan and China investing in advanced molecular diagnostics.
- South America: Brazil and Argentina showing gradual adoption of diagnostic devices.
- Middle East & Africa: Limited prevalence but increasing adoption of advanced diagnostic technologies in urban centers.
Key Players
- Abbott Laboratories
- Canon U.S. Life Sciences
- Bio-Rad Laboratories
- Graphene Frontiers
- Boulder Diagnostics
- Immunetics Inc.
- Baxter International Inc.
- Additional Players:
- Roche Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
- Qiagen N.V.
- PerkinElmer Inc.
- Danaher Corporation (Cepheid, Beckman Coulter)
- Hologic Inc.
- Quest Diagnostics
- LabCorp
Porter’s Five Forces
- Threat of New Entrants: Moderate – high R&D costs and regulatory approvals limit entry.
- Bargaining Power of Suppliers: Moderate – reliance on specialized reagents and molecular testing kits.
- Bargaining Power of Buyers: High – hospitals and diagnostic centers demand cost-effective, accurate solutions.
- Threat of Substitutes: Moderate – clinical diagnosis and alternative tests exist but lack accuracy.
- Industry Rivalry: High – intense competition among global diagnostic device manufacturers.
SWOT Analysis
Strengths
- Advanced molecular diagnostic technologies
- Strong presence of multinational diagnostic companies
- Growing awareness and screening programs
Weaknesses
- High cost of advanced diagnostic devices
- Limited availability in rural and low-income regions
Opportunities
- Expansion of point-of-care testing devices
- Integration of AI and digital health platforms
- Rising demand in emerging markets
Threats
- Stringent regulatory approvals
- Competition from alternative diagnostic methods
- Risk of false positives/negatives impacting trust
Trend Analysis
- Increasing adoption of point-of-care molecular diagnostics.
- Integration of AI and machine learning for improved accuracy.
- Rising demand for multiplex assays detecting multiple pathogens simultaneously.
- Expansion of telemedicine and remote diagnostics.
- Growing focus on next-generation sequencing (NGS) for precision diagnostics.
Drivers
- Rising incidence of Lyme disease globally.
- Growing awareness and government initiatives for early detection.
- Technological advancements in molecular diagnostics.
- Expansion of healthcare infrastructure in emerging markets.
Challenges
- High cost of advanced diagnostic devices.
- Limited awareness in developing regions.
- Regulatory hurdles for new diagnostic technologies.
- Risk of misdiagnosis due to overlapping symptoms with other diseases.
Value Chain Analysis
- Raw Material Suppliers – Reagents, consumables, and diagnostic components.
- Device Manufacturers – Global diagnostic companies developing and producing devices.
- Distributors & Wholesalers – Supply chain intermediaries ensuring device availability.
- Healthcare Providers – Hospitals, diagnostic centers, research institutes.
- End Users – Patients requiring accurate and timely diagnosis.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in point-of-care and AI-integrated diagnostic platforms.
- Healthcare Providers: Expand awareness campaigns and screening programs.
- Investors: Focus on North America and Europe for established demand; Asia-Pacific for growth potential.
- Policy Makers: Streamline regulatory approvals and support affordable diagnostics.
- Distributors: Strengthen e-commerce and telemedicine partnerships for wider reach.
Explore more reports here-
https://westernmarketresearch.com/reports
1. Market Overview of Lyme Disease Diagnostic Devices
1.1 Lyme Disease Diagnostic Devices Market Overview
1.1.1 Lyme Disease Diagnostic Devices Product Scope
1.1.2 Market Status and Outlook
1.2 Lyme Disease Diagnostic Devices Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Lyme Disease Diagnostic Devices Historic Market Size by Regions
1.4 Lyme Disease Diagnostic Devices Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Lyme Disease Diagnostic Devices Sales Market by Type
2.1 Global Lyme Disease Diagnostic Devices Historic Market Size by Type
2.2 Global Lyme Disease Diagnostic Devices Forecasted Market Size by Type
2.3 Serological
2.4 Lymphocytic Transformation
2.5 PCR Analysis
2.6 Immunofluorescence Staining
3. Covid-19 Impact Lyme Disease Diagnostic Devices Sales Market by Application
3.1 Global Lyme Disease Diagnostic Devices Historic Market Size by Application
3.2 Global Lyme Disease Diagnostic Devices Forecasted Market Size by Application
3.3 Application 1
3.4 Application 2
3.5 Other
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Lyme Disease Diagnostic Devices Production Capacity Market Share by Manufacturers
4.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Manufacturers
4.3 Global Lyme Disease Diagnostic Devices Average Price by Manufacturers
5. Company Profiles and Key Figures in Lyme Disease Diagnostic Devices Business
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Company Profile
5.1.2 Abbott Laboratories Lyme Disease Diagnostic Devices Product Specification
5.1.3 Abbott Laboratories Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
5.2 Canon U.S. Life Sciences
5.2.1 Canon U.S. Life Sciences Company Profile
5.2.2 Canon U.S. Life Sciences Lyme Disease Diagnostic Devices Product Specification
5.2.3 Canon U.S. Life Sciences Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Company Profile
5.3.2 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Product Specification
5.3.3 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
5.4 Graphene Frontiers
5.4.1 Graphene Frontiers Company Profile
5.4.2 Graphene Frontiers Lyme Disease Diagnostic Devices Product Specification
5.4.3 Graphene Frontiers Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
5.5 Boulder Diagnostics
5.5.1 Boulder Diagnostics Company Profile
5.5.2 Boulder Diagnostics Lyme Disease Diagnostic Devices Product Specification
5.5.3 Boulder Diagnostics Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
5.6 Immunetics Inc.
5.6.1 Immunetics Inc. Company Profile
5.6.2 Immunetics Inc. Lyme Disease Diagnostic Devices Product Specification
5.6.3 Immunetics Inc. Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
5.7 Baxter International Inc.
5.7.1 Baxter International Inc. Company Profile
5.7.2 Baxter International Inc. Lyme Disease Diagnostic Devices Product Specification
5.7.3 Baxter International Inc. Lyme Disease Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Lyme Disease Diagnostic Devices Market Size
6.2 North America Lyme Disease Diagnostic Devices Key Players in North America
6.3 North America Lyme Disease Diagnostic Devices Market Size by Type
6.4 North America Lyme Disease Diagnostic Devices Market Size by Application
7. East Asia
7.1 East Asia Lyme Disease Diagnostic Devices Market Size
7.2 East Asia Lyme Disease Diagnostic Devices Key Players in North America
7.3 East Asia Lyme Disease Diagnostic Devices Market Size by Type
7.4 East Asia Lyme Disease Diagnostic Devices Market Size by Application
8. Europe
8.1 Europe Lyme Disease Diagnostic Devices Market Size
8.2 Europe Lyme Disease Diagnostic Devices Key Players in North America
8.3 Europe Lyme Disease Diagnostic Devices Market Size by Type
8.4 Europe Lyme Disease Diagnostic Devices Market Size by Application
9. South Asia
9.1 South Asia Lyme Disease Diagnostic Devices Market Size
9.2 South Asia Lyme Disease Diagnostic Devices Key Players in North America
9.3 South Asia Lyme Disease Diagnostic Devices Market Size by Type
9.4 South Asia Lyme Disease Diagnostic Devices Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Lyme Disease Diagnostic Devices Market Size
10.2 Southeast Asia Lyme Disease Diagnostic Devices Key Players in North America
10.3 Southeast Asia Lyme Disease Diagnostic Devices Market Size by Type
10.4 Southeast Asia Lyme Disease Diagnostic Devices Market Size by Application
11. Middle East
11.1 Middle East Lyme Disease Diagnostic Devices Market Size
11.2 Middle East Lyme Disease Diagnostic Devices Key Players in North America
11.3 Middle East Lyme Disease Diagnostic Devices Market Size by Type
11.4 Middle East Lyme Disease Diagnostic Devices Market Size by Application
12. Africa
12.1 Africa Lyme Disease Diagnostic Devices Market Size
12.2 Africa Lyme Disease Diagnostic Devices Key Players in North America
12.3 Africa Lyme Disease Diagnostic Devices Market Size by Type
12.4 Africa Lyme Disease Diagnostic Devices Market Size by Application
13. Oceania
13.1 Oceania Lyme Disease Diagnostic Devices Market Size
13.2 Oceania Lyme Disease Diagnostic Devices Key Players in North America
13.3 Oceania Lyme Disease Diagnostic Devices Market Size by Type
13.4 Oceania Lyme Disease Diagnostic Devices Market Size by Application
14. South America
14.1 South America Lyme Disease Diagnostic Devices Market Size
14.2 South America Lyme Disease Diagnostic Devices Key Players in North America
14.3 South America Lyme Disease Diagnostic Devices Market Size by Type
14.4 South America Lyme Disease Diagnostic Devices Market Size by Application
15. Rest of the World
15.1 Rest of the World Lyme Disease Diagnostic Devices Market Size
15.2 Rest of the World Lyme Disease Diagnostic Devices Key Players in North America
15.3 Rest of the World Lyme Disease Diagnostic Devices Market Size by Type
15.4 Rest of the World Lyme Disease Diagnostic Devices Market Size by Application
16 Lyme Disease Diagnostic Devices Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Market Segmentation
By Type
- Serological Tests (ELISA, Western Blot)
- Lymphocytic Transformation Tests
- PCR Analysis (Polymerase Chain Reaction)
- Immunofluorescence Staining
- Rapid Point-of-Care Tests
- Next-Generation Sequencing (NGS)-based Assays
By Application
- Hospital Laboratories
- Diagnostic Centers
- Research Institutes
- Point-of-Care Testing (POCT)
- Others
Regional Analysis
- North America: Largest market share due to high prevalence of Lyme disease in the U.S. and Canada, strong healthcare infrastructure, and advanced diagnostic technologies.
- Europe: Significant demand in Germany, U.K., and France; Eastern Europe shows rising incidence rates.
- Asia-Pacific: Emerging market with growing awareness; Japan and China investing in advanced molecular diagnostics.
- South America: Brazil and Argentina showing gradual adoption of diagnostic devices.
- Middle East & Africa: Limited prevalence but increasing adoption of advanced diagnostic technologies in urban centers.
Key Players
- Abbott Laboratories
- Canon U.S. Life Sciences
- Bio-Rad Laboratories
- Graphene Frontiers
- Boulder Diagnostics
- Immunetics Inc.
- Baxter International Inc.
- Additional Players:
- Roche Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
- Qiagen N.V.
- PerkinElmer Inc.
- Danaher Corporation (Cepheid, Beckman Coulter)
- Hologic Inc.
- Quest Diagnostics
- LabCorp
